Nuclear protein interactions with the human KDR/flk-1 promoter in vivo - Regulation of Sp1 binding is associated with cell type-specific expression

被引:46
作者
Patterson, C [1 ]
Wu, YX [1 ]
Lee, ME [1 ]
DeVault, JD [1 ]
Runge, MS [1 ]
Haber, E [1 ]
机构
[1] HARVARD UNIV, SCH PUBL HLTH, CARDIOVASC BIOL LAB, BOSTON, MA 02115 USA
关键词
D O I
10.1074/jbc.272.13.8410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The endothelial cell type-specific tyrosine kinase KDR/flk-1 is a receptor for vascular endothelial growth factor and a critical regulator of endothelial cell growth and development. To study mechanisms of endothelial cell differentiation and gene regulation, we have analyzed the topology of the proximal promoter of human KDR/flk-1. A protected sequence between base pairs -110 and -25 was defined by in vitro DNase I footprinting analysis in human umbilical vein endothelial cells (HUVECs), Purified Sp1 alone produced similar protection, and electrophoretic mobility shift assays demonstrated that Sp1 was indeed the major nuclear protein binding to this region, Despite the cell type specificity of KDR/flk-1 expression, no cell type differences were observed in DNA-protein interactions in vitro, In contrast, in vivo footprinting assays demonstrated marked differences in core promoter interactions between cell types, Protection of Sp1 binding sites was observed in HUVECs by in vivo DNase I footprinting, whereas in human fibroblasts and HeLa cells a pattern consistent with nucleosomal positioning was observed. In vivo dimethylsulfate footprinting confirmed that DNA-protein interactions occurred within Sp1 elements in HUVECs but not in nonendothelial cells. It is possible that distant elements coordinate Sp1 binding and chromatin structure to regulate cell type-specific expression of KDR/flk-1.
引用
收藏
页码:8410 / 8416
页数:7
相关论文
共 46 条
[1]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[2]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[3]  
Ausubel FM, 1995, CURRENT PROTOCOLS MO
[4]   Multiple Sp1 binding sites in the cardiac slow twitch muscle sarcoplamsic reticulum Ca2+-ATPase gene promoter are required for expression in Sol8 muscle cells [J].
Baker, DL ;
Dave, V ;
Reed, T ;
Periasamy, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5921-5928
[5]   PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PROMOTER-SPECIFIC TRANSCRIPTION FACTOR, SPL [J].
BRIGGS, MR ;
KADONAGA, JT ;
BELL, SP ;
TJIAN, R .
SCIENCE, 1986, 234 (4772) :47-52
[6]   A HISTONE-BINDING PROTEIN, NUCLEOPLASMIN, STIMULATES TRANSCRIPTION FACTOR-BINDING TO NUCLEOSOMES AND FACTOR-INDUCED NUCLEOSOME DISASSEMBLY [J].
CHEN, H ;
LI, BY ;
WORKMAN, JL .
EMBO JOURNAL, 1994, 13 (02) :380-390
[7]   INITIATION OF TRANSCRIPTION BY RNA POLYMERASE-II IN PERMEABLE, SV40-INFECTED OR NONINFECTED, CV1 CELLS - EVIDENCE FOR MULTIPLE PROMOTERS OF SV40 LATE TRANSCRIPTION [J].
CONTRERAS, R ;
FIERS, W .
NUCLEIC ACIDS RESEARCH, 1981, 9 (02) :215-236
[8]   In vivo footprinting analysis of the hepatic control region of the human apolipoprotein E/C-I/C-IV/C-II gene locus [J].
Dang, Q ;
Taylor, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28667-28676
[9]   Novel role for Sp1 in phorbol ester enhancement of human platelet thromboxane receptor gene expression [J].
DAngelo, DD ;
Oliver, BG ;
Davis, MG ;
McCluskey, TS ;
Dorn, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) :19696-19704
[10]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991